Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline Papeix

Showing results (41-50 of 159) with videos related to

Pageof 16
Sort By:
International Journal of Rheumatic Diseases|September 2, 2024
Neurosarcoidosis: A good reason for a brainstormLina Jeantin, Emeline Chaugne, Marine Boudot de la Motte, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 4, 2024
Multiple sclerosis reactivations after fingolimod discontinuation for pregnancy planningLina Jeantin, Caroline Bensa-Koscher, Romain Deschamps, et al.
Multiple Sclerosis and Related Disorders|August 31, 2020
Reasons for switching to fingolimod in patients relapsing-remitting multiple sclerosis in France: the ESGILE studyAyman Tourbah, Caroline Papeix, Patricia Tourniaire, et al.
Multiple Sclerosis and Related Disorders|December 1, 2019
Secondary hypersomnia as an initial manifestation of neuromyelitis optica spectrum disordersYsoline Beigneux, Isabelle Arnulf, Perrine Guillaume-Jugnot, et al.
Journal of the Neurological Sciences|March 18, 2019
Early radiological features of severe longitudinally extensive transverse myelitis over timeSamuel Cattan, Caroline Papeix, David Grabli, et al.
Annals of Intensive Care|January 7, 2024
Risk factors and prognosis of orotracheal intubation in aquaporin-4-IgG neuromyelitis optica spectrum disorder attacksEdouard Januel, Vincent Brochard, Loïc Le Guennec, et al.
Journal of the Neurological Sciences|May 21, 2023
Natalizumab extended-interval dosing in a real-life settingLina Jeantin, Marine Boudot de la Motte, Romain Deschamps, et al.
Multiple Sclerosis and Related Disorders|May 18, 2021
Challenges of switching towards anti-CD20 monoclonal antibodies in RR-MS: A monocentric studyMarine Boudot de la Motte, Céline Louapre, Caroline Papeix, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|February 27, 2020
Dramatic efficacy of ofatumumab in refractory pediatric-onset AQP4-IgG neuromyelitis optica spectrum disorderElisabeth Maillart, Florence Renaldo, Caroline Papeix, et al.
Multiple Sclerosis and Related Disorders|March 20, 2015
High doses of biotin in chronic progressive multiple sclerosis: a pilot studyFrédéric Sedel, Caroline Papeix, Agnès Bellanger, et al.
Pageof 16

Showing results (41-50 of 159) with videos related to

Sort By:
Pageof 16
International Journal of Rheumatic Diseases|September 2, 2024
Neurosarcoidosis: A good reason for a brainstormLina Jeantin, Emeline Chaugne, Marine Boudot de la Motte, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 4, 2024
Multiple sclerosis reactivations after fingolimod discontinuation for pregnancy planningLina Jeantin, Caroline Bensa-Koscher, Romain Deschamps, et al.
Multiple Sclerosis and Related Disorders|August 31, 2020
Reasons for switching to fingolimod in patients relapsing-remitting multiple sclerosis in France: the ESGILE studyAyman Tourbah, Caroline Papeix, Patricia Tourniaire, et al.
Multiple Sclerosis and Related Disorders|December 1, 2019
Secondary hypersomnia as an initial manifestation of neuromyelitis optica spectrum disordersYsoline Beigneux, Isabelle Arnulf, Perrine Guillaume-Jugnot, et al.
Journal of the Neurological Sciences|March 18, 2019
Early radiological features of severe longitudinally extensive transverse myelitis over timeSamuel Cattan, Caroline Papeix, David Grabli, et al.
Annals of Intensive Care|January 7, 2024
Risk factors and prognosis of orotracheal intubation in aquaporin-4-IgG neuromyelitis optica spectrum disorder attacksEdouard Januel, Vincent Brochard, Loïc Le Guennec, et al.
Journal of the Neurological Sciences|May 21, 2023
Natalizumab extended-interval dosing in a real-life settingLina Jeantin, Marine Boudot de la Motte, Romain Deschamps, et al.
Multiple Sclerosis and Related Disorders|May 18, 2021
Challenges of switching towards anti-CD20 monoclonal antibodies in RR-MS: A monocentric studyMarine Boudot de la Motte, Céline Louapre, Caroline Papeix, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|February 27, 2020
Dramatic efficacy of ofatumumab in refractory pediatric-onset AQP4-IgG neuromyelitis optica spectrum disorderElisabeth Maillart, Florence Renaldo, Caroline Papeix, et al.
Multiple Sclerosis and Related Disorders|March 20, 2015
High doses of biotin in chronic progressive multiple sclerosis: a pilot studyFrédéric Sedel, Caroline Papeix, Agnès Bellanger, et al.
Pageof 16